U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2015
471
Substance Class Protein
Created
by admin
on Sat Dec 16 01:12:12 GMT 2023
Edited
by admin
on Sat Dec 16 01:12:12 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
1351PE5UGS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ELOTUZUMAB
DASH   INN   USAN   WHO-DD  
INN   USAN  
Official Name English
Elotuzumab [WHO-DD]
Common Name English
HULUC63
Code English
elotuzumab [INN]
Common Name English
PDL063
Code English
ELOTUZUMAB [USAN]
Common Name English
BMS-901608
Code English
ELOTUZUMAB [PURPLE BOOK CDER]
Common Name English
ELOTUZUMAB [JAN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROTEIN CS1) (HUMAN-MOUSE HULUC63 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE HULUC63 .KAPPA.-CHAIN, DIMER
Common Name English
EMPLICITI
Brand Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROTEIN CS1) (HUMAN-MOUSE HULUC63 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE HULUC63 .KAPPA.-CHAIN, DIMER
Common Name English
ELOTUZUMAB [MI]
Common Name English
PDL-063
Code English
Classification Tree Code System Code
EU-Orphan Drug EU/3/12/1037
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
NDF-RT N0000192338
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
EMA ASSESSMENT REPORTS EMPLICITI (AUTHORIZED: MULTIPLE MYELOMA)
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
FDA ORPHAN DRUG 348411
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
WHO-ATC L01XC23
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
NCI_THESAURUS C129822
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
Code System Code Type Description
NDF-RT
N0000192337
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY SLAMF7-directed Antibody Interactions [MoA]
SMS_ID
100000144872
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY
INN
9074
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY
DRUG CENTRAL
5072
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY
FDA UNII
1351PE5UGS
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY
DAILYMED
1351PE5UGS
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY
WIKIPEDIA
ELOTUZUMAB
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY
CAS
915296-00-3
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY
EVMPD
SUB121695
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY
ChEMBL
CHEMBL1743010
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY
DRUG BANK
DB06317
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY
RXCUI
1726104
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY RxNorm
NCI_THESAURUS
C66982
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY
USAN
TT-69
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY
LACTMED
Elotuzumab
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY
MERCK INDEX
m11900
Created by admin on Sat Dec 16 01:12:12 GMT 2023 , Edited by admin on Sat Dec 16 01:12:12 GMT 2023
PRIMARY
From To
1_22 1_96
1_146 1_202
1_222 3_214
1_228 2_228
1_231 2_231
1_263 1_323
1_369 1_427
2_22 2_96
2_146 2_202
2_222 4_214
2_263 2_323
2_369 2_427
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Related Record Type Details
SLAM FAMILY MEMBER 7
TARGET -> AGONIST
Related Record Type Details
ELOTUZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:SEQUENCE CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966